Nina Kim

8PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMolecular medicineChemical engineering designMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.

Nina Kim, E Dianne Pulte, Lori A Ehrlich

|Jan 09, 2025
Advancing drug development in myelodysplastic syndromes.

Alain Mina, Kathy L McGraw, Lea Cunningham

|Jan 23, 2023
Considerations for Drug Development in Myelodysplastic Syndromes.

Mikkael A Sekeres, Nina Kim, Amy E DeZern

|Apr 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes.

Nina Kim, Kelly J Norsworthy, Sriram Subramaniam

|Oct 10, 2021
Meaningful response criteria for myelodysplastic syndromes.

Nina Kim, Steven Pavletic, Kelly J Norsworthy

Pageof 2

Frequent Collaborators

5 joint publications

Rami S Komrokji

4 joint publications

Lori A Ehrlich

4 joint publications

Mikkael Sekeres

3 joint publications

Kelly J Norsworthy